Improving the Outcome of High-risk Aggressive B-cell Lymphoma Patients With Nivolumab Maintenance Therapy
Clinical trial NCT03569696 · UNKNOWN
Trial details
- NCT number
- NCT03569696
- Sponsor
- Meirav Kedmi MD
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-10-08
- Primary completion
- 2023-07-01
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.